Rxsight Price To Sales Ratio from 2010 to 2024
| RXST Stock | USD 50.38 0.81 1.63% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 15.59583367 | Current Value 14.82 | Quarterly Volatility 88.41480956 |
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
Rxsight | Price To Sales Ratio |
Latest Rxsight's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Rxsight over the last few years. Price to Sales Ratio is figured by comparing Rxsight stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Rxsight sales, a figure that is much harder to manipulate than other Rxsight multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Rxsight's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 17.08 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Rxsight Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 136.90 | |
| Geometric Mean | 82.93 | |
| Coefficient Of Variation | 64.58 | |
| Mean Deviation | 80.43 | |
| Median | 197.22 | |
| Standard Deviation | 88.41 | |
| Sample Variance | 7,817 | |
| Range | 190 | |
| R-Value | (0.82) | |
| Mean Square Error | 2,724 | |
| R-Squared | 0.68 | |
| Significance | 0.0002 | |
| Slope | (16.26) | |
| Total Sum of Squares | 109,440 |
Rxsight Price To Sales Ratio History
About Rxsight Financial Statements
Rxsight shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 15.60 | 14.82 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.